Advertisement

Topics

Discuva Announces Extension of Ongoing Pharma Collaboration to Combat Life-Threatening Infections Caused by Multi-Drug Resistant Bacteria

03:00 EST 21 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Discuva Ltd, the antibiotics drug discovery and development company, today announced that its collaboration with Roche, originally initiated in February 2014, has been extended to February 2018 under a new contract amendm...

Other Sources for this Article

Discuva
David Williams, Chief Executive Officer
Tel: +44 (0) 1223 394200
Email: info@discuva.com
or
Halsin Partners (media)
Mike Sinclair
Tel: +44 (0)20 7318 2955
Email: msinclair@halsin.com

NEXT ARTICLE

More From BioPortfolio on "Discuva Announces Extension of Ongoing Pharma Collaboration to Combat Life-Threatening Infections Caused by Multi-Drug Resistant Bacteria"

Advertisement
Quick Search
Advertisement
Advertisement